Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • partial_accumen@lemmy.world
    link
    fedilink
    English
    arrow-up
    34
    ·
    1 year ago

    The real dystopian horror is when these genetics companies start selling to insurance companies. Think about it:

    “I’m sorry we aren’t covering this cancer claim with our health insurance product because you are genetically predisposed to it”

    We need legislation now to prevent genetic discrimination.